|
|
||||||||
Helicobacter pylori urease is required to counteract acidity during colonization of the stomach, and has been suggested as a major immunodominant antigen. The aim of this study was to determine the anti-urease response in a representative national serologic survey in Mexico. The population surveyed included persons 1-90 years of age from all socioeconomic levels and geographic zones of the country. Helicobacter pylori status was determined by ELISA serology. The IgG anti-urease was studied by ELISA using a recombinant apoenzyme. We found that 2,930 of the 7,720 infected patients (38%) were seropositive for IgG urease. The rate of IgG anti-urease positivity increased with age; in children < 10 years old it was < 20% and in persons > 40 years old it was > 50%. Age and a region with a high level of development were risk factors for seropositivity, whereas gender, educational level, crowding, and socioeconomic level were not associated with seropositivity. In conclusion, in natural infection with H. pylori, the response to urease is poor, mainly during the first years of infection. This inconsistent immune response to the enzyme may favor persistence of infection. A vaccine eliciting a consistent anti-urease response might overcome immune evasion and enhance clearance of bacteria after exposure.
This article has been cited by other articles:
![]() |
S. Y. Chui, T. M. Clay, H. K. Lyerly, and M. A. Morse The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1883 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. H. Hoang, C. Bengtsson, D. C. Phung, M. Sorberg, and M. Granstrom Seroprevalence of Helicobacter pylori Infection in Urban and Rural Vietnam Clin. Vaccine Immunol., January 1, 2005; 12(1): 81 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bode, I. Piechotowski, D. Rothenbacher, and H. Brenner Helicobacter pylori-Specific Immune Responses of Children: Implications for Future Vaccination Strategy Clin. Vaccine Immunol., September 1, 2002; 9(5): 1126 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Londono-Arcila, D. Freeman, H. Kleanthous, A. M. O'Dowd, S. Lewis, A. K. Turner, E. L. Rees, T. J. Tibbitts, J. Greenwood, T. P. Monath, et al. Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen Infect. Immun., September 1, 2002; 70(9): 5096 - 5106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Torres, M. Camorlinga-Ponce, G. Perez-Perez, L. Munoz, and O. Munoz Specific Serum Immunoglobulin G Response to Urease and CagA Antigens of Helicobacter pylori in Infected Children and Adults in a Country with High Prevalence of Infection Clin. Vaccine Immunol., January 1, 2002; 9(1): 97 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirota, K. Nagata, Y. Norose, S. Futagami, Y. Nakagawa, H. Senpuku, M. Kobayashi, and H. Takahashi Identification of an Antigenic Epitope in Helicobacter pylori Urease That Induces Neutralizing Antibody Production Infect. Immun., November 1, 2001; 69(11): 6597 - 6603. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |